Value of bevacizumab in treatment of colorectal cancer: A meta-analysis

doi:10.3748/wjg.v21.i16.5072

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8692)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-1) series.

Item

Count

PDF

511

WORD

240

HTML

4803

Figures (1-10)

190

Tables (1-1)

213

Sum=5957

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1120

Download

1615

Sum=2735

Apr 28, 2015 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (54)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Apr 28, 2015; 21(16): 5072-5080
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.5072

Full Size Figure Download Figure

Figure 3 Forest plot of meta-analysis: Effect of bevacizumab on progression-free survival.

Citation: Qu CY, Zheng Y, Zhou M, Zhang Y, Shen F, Cao J, Xu LM. Value of bevacizumab in treatment of colorectal cancer: A meta-analysis. World J Gastroenterol 2015; 21(16): 5072-5080
URL: https://www.wjgnet.com/1007-9327/full/v21/i16/5072.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i16.5072